Session Details
[26PO10-pm1]Pathological models-1/Genes and gene therapy of diseases/Clinical biochemistry/Others
Sat. Mar 26, 2022 1:30 PM - 3:10 PM JST
Sat. Mar 26, 2022 4:30 AM - 6:10 AM UTC
Sat. Mar 26, 2022 4:30 AM - 6:10 AM UTC
[Room PO10] Lounge in front of Room D Bldg. 1: 4F
【説明時間】13:45～14:55
[26PO10-pm1-01S]Attenuation of cognitive decline in APP/PS1 mouse model of Alzheimer’s disease by vascular endothelial cell senescence
○Keiko Maeda1, Sayo Horibe1, Mio Kanda1, Wakana Komabayashi1, Tomomi Sakaguchi1, Mei Narimatsu1, Mao Mizoue1, Syouji Kawauchi1, Toru Tanaka1, Naoto Sasaki1, Kouji Ikeda1,2, Noriaki Emoto1, Kenichi Hirata3, Yoshiyuki Rikutake1 (1. Kobe Pharm. Univ., 2. Kyoto Pre. Univ. Med, 3. Grad. Sch. Med. Kobe Univ.)
[26PO10-pm1-02S]Role of endothelial cell senescence in the association between Alzheimer’s disease and diabetes mellitus
○Mei Narimatsu1, Sayo Horibe1, Mio Kanda1, Wakana Komabayashi1, Tomomi Sakaguchi1, Keiko Maeda1, Mao Mizoue1, Syouji Kawauchi1, Toru Tanaka1, Naoto Sasaki1, Kouji Ikeda1,2, Noriaki Emoto1, Kenichi Hirata3, Yoshiyuki Rikutake1 (1. Kobe Pharm. Univ., 2. Kyoto Pre. Univ. Med, 3. Grad. Sch. Med. Kobe Univ.)
[26PO10-pm1-03S]The effect of drug-induced nonalcoholic steatohepatitis (NASH) on intestinal barrier function.
○Rio Nishikori1, Shoji Kawauchi1, Mizuki Okii1, Yuka Tanaka1, Toru Tanaka1, Sayo Horibe1, Naoto Sasaki1, Yoshiyuki Rikitake1, Junichi Kunimasa1 (1. Kobe Pharmaceutical University)
[26PO10-pm1-04]Sasa veitchii extract decreases ethanol-induced acute hepatotoxicity in mice
○Hiroki Yoshioka1,2,3, Mai Nishikawa2, Mayuko Sakanashi2, Hirohisa Fujii2,4, Makoto Nakao2 (1. University of Texas Health Science Center at Houston, 2. Department of Pharmacy, Kinjo Gakuin University, 3. Department of pharmacy, Gifu University of Medical Science, 4. Sunchlon Co., Ltd )
[26PO10-pm1-05S]Examination of fibrosis model in dextran sodium sulfate-induced chronic colitis
○Reiichiro Sasaki1, Miyu Yamamoto2, Miyoko Takahashi2, Kikuko Amagase1,2 (1. Lab. of Pharmacol. & Pharmacother., Grad. Sch. of Pharmacy, Ritsumeikan Univ.,, 2. Lab. of Pharmacol. & Pharmacother., College of Pharm. Sci. Ritsumeikan Univ.,)
[26PO10-pm1-06]Effects of a mast cell stabilizer and antibiotics in GFAP-Cre calcineurin Bαfl/fl mice in which small intestine inflammation is induced
Yuri Tanahashi1, Naohide Hirashima1, ○Masahiko Tanaka1 (1. Grad. Sch. Pharmaceut. Sci., Nagoya City Univ.)
[26PO10-pm1-07]Proposal of a new animal model for seasonal affective disorder (SAD) and search for factors contributing to SAD
○Mari Tomonari1,2, Haruna Urabe1, Hideto To1,2 (1. Grad. Sch. Med. and Pharm. Sci, Toyama Univ., 2. Toyama Com. Med. Lab.)
[26PO10-pm1-08]Analysis of SMN gene using MALDI-TOF MS
○Atsuko Takeuchi1, Takahiro Mimura1, Chisato Tode1, Hisahide Nishio2 (1. Kobe Pharmaceutical University, 2. Kobe Gakuin University)
[26PO10-pm1-09S]Therapeutic effect of high-level expression of Peroxisomal biogenesis factor 11α in the liver on lipid metabolism
○Misato Miyauchi1, Kahori Shimizu1, Moka Mitsukawa1, Ayaka Kato1, Fuminori Sakurai2, Hiroyuki Mizuguchi2,3,4,5, Koji Tomita1, Toru Nishinaka1 (1. Pharm., Osaka Ohtani Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. Natl. Inst. Biomed. Innov. Health Nutr., 4. MEIC, Osaka Univ., 5. OTRI, Osaka Univ.)
[26PO10-pm1-10S]Therapeutic effect of high-level expression of type 2 diabetes susceptibility gene “ASB3” in the liver using an improved adenovirus on glucose and lipid metabolism
○Moka Mitsukawa1, Kahori Shimizu1, Misato Miyauchi1, Iori Tokiwa1, Momoka Terada1, Tomoyuki Terada1, Fuminori Sakurai2, Hiroyuki Mizuguchi2,3,4,5, Koji Tomita1, Toru Nishinaka1 (1. Pharm., Osaka Ohtani Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. Natl. Inst. Biomed. Innov. Health Nutr., 4. MEIC, Osaka Univ., 5. OTRI, Osaka Univ.)
[26PO10-pm1-11]Assisting the diagnosis of overt hypothyroidism making use of a set of routine tests: Artificial intelligence-based attempts to build a time-series prediction model using laboratory values at two-time points
○Sorama Aoki1, Junko Kawakami1, Kenji Hoshi1, Kenichi Sato2, Yoshinori Nakagawa3, Kouki Mori4, Wataru Hida5, Katsumi Yoshida5 (1. Tohoku Med. Pharm. Univ., 2. Cosmos Med. Info. AI Analysis Lab., 3. Sendai Thyroid Clinic, 4. JR Sendai Hosp., 5. Tohoku Kosai Hosp.)
[26PO10-pm1-12]Analysis of multiple myeloma cell surface sugar chain by cytokine stimulation
○Shiro Iijima1, kandai nakanishi1, etsuko Itho1, mihiro Fujita1, satoka Simogaki1 (1. Fac. Health Sci. Tech. Bunkyo Gakuin Univ.)
[26PO10-pm1-13]Leucine rich-repeat kinase 2-mediated regulation of GLUT4 membrane translocation in adipocyte and blood glucose level.
○Fumitaka Kawakami1,2, Motoki Imai1, Rei Kawashima1,2, Tatsunori Maekawa1,2, Shun Tamaki2, Takatoshi Yabata2, Takafumi Ichikawa1,2 (1. Grad. Sch. Med. Sci., Reg. Biochem., Kitasato Univ., 2. Sch. Allied Health Sci., Pathol. Biochem., Kitasato Univ. )
[26PO10-pm1-14S]Development of quantitative assay for protein C, blood coagulation regulation factor, and evalulation of its deficiency.
○Mutsumi Kobayashi1, Shiori Sakata1, Ryo Matsuda1, Eri Nakao1, Nozomi Ohkuma1, Hinako Hatae1, Hiroyuki Kuma1 (1. Division of Clinical Chemistry and Laboratory Medicine,Faculty of Pharmaceutical Sciences,Nagasaki International University)
[26PO10-pm1-15S]Quantitative analysis of Dabigatran in human blood with peptide substrate.
○Ai Yutaka1, Keigo Takashima1, Moe Kaise1, Satoko Shono1, Hinako Hatae1, Hiroyuki Kuma1 (1. Division of Clinical Chemistry and Laboratory Medicine, Faculty of Pharmaceutical, Nagasaki International University)
[26PO10-pm1-16S]Risk analysis of postoparative venous thromboembolism by measurement of protein S specific activity.
○Reiko Tsuchiya1, Hinako Hatae1, Yasuyuki Abe2, Hiroyuki Kuma1 (1. Division of Clinical Chemistry and Laboratory Medicine, Faculty of Pharmaceutical Sciences, Nagasaki International University, 2. Department of Orthopaedic Surgery, Kumamoto Chuo Hospital)
[26PO10-pm1-17]Development of a cell line expressing a chimeric IgE receptor and a sensitive test method for type 1 allergy
○Haruyo AKIYAMA1, Chisato KURISAKA1, Satoshi TADOKORO2, Kenichi KUMASAKA2, Ryosuke NAKAMURA3 (1. Fac. Pharm. Sci., Teikyo Heisei Univ., 2. Kanagawa Pref. Inst. Public Health, 3. Natl. Inst. Health Sci.)